Isavuconazole Treatment of a Patient with Disseminated Mucormycosis
Author(s) -
Driele Peixoto,
Lisa S. Gagne,
Sarah P. Hammond,
Erin T. Gilmore,
Amy Joyce,
Robert J. Soiffer,
Francisco M. Marty
Publication year - 2014
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.03176-13
Subject(s) - mucormycosis , medicine , mycosis , intensive care medicine , pathology , surgery
We report a patient with relapsed acute myelogenous leukemia after allogeneic stem cell transplantation who developed disseminated mucormycosis due to Rhizomucor pusillus/R. miehei involving lung, brain, and skin. After failing posaconazole and being intolerant to amphotericin, he was treated effectively with isavuconazole for over 6 months despite ongoing treatment for relapsed leukemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom